New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations

新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践

基本信息

  • 批准号:
    10175561
  • 负责人:
  • 金额:
    $ 14.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-01 至 2024-02-28
  • 项目状态:
    已结题

项目摘要

As early as February of 2020, American Indian and Alaska Native (AI/AN) communities began to report increased prevalence rates of COVID-19 relative to the rest of the US. Compared to non-NHWs (21%), 34% of AI/AN adults are at greatest risk of COVID-19 related serious illness. AI/AN adults are also more likely to suffer from underlying health conditions that further increases vulnerability to COVID-19 infection, such as diabetes, cardiovascular disease, and cancer. These elevated risks are exacerbated by historical and political factors, including population collapses from smallpox and the Spanish flu, low socioeconomic status, obstacles to accessing needed care and chronic underfunding of the Indian Health Service. To vividly illustrate COVID-19-related disparities, AI/AN people comprise ~11% of the New Mexico population, yet account for more than 55% of COVID-19 cases in the state,10 with the Navajo Nation reporting 3,912 confirmed cases and 140 deaths (as of 5/21/20). To address the treatment needs of people with substance use disorders, especially opioid use disorder (OUD), during the COVID-19 emergency, federal regulations guiding addiction services delivery have been modified, including within AI/AN communities. Changes include expansion of telemedicine and virtual behavioral health delivery, adjusting medication dosing strategies for OUD, and altering reimbursement and confidentiality policies and practices for addiction services. Although these policy shifts were to promote availability and access, little is known about the adoption, implementation, and effectiveness of these changes among programs serving AI/AN communities. Data is critically needed to inform policy decisions following the COVID-19 emergency – that is, should policies be further developed and expanded or, alternatively, rolled back. In order to ensure future policies decisions about addiction service include experiences and needs of AI/AN communities, rapid research on the dissemination, adoption, and implementation of federal addiction policies among AI/AN-serving addiction treatment programs is of vital importance. The goal of this study is to rapidly investigate the dissemination, adoption, implementation, and sustainment of substance use and COVID-19 related policy changes among Tribal communities. The specific aims are to assess the dissemination, adoption, and implementation of COVID- 19 policy and regulations at Tribal, State, and Federal levels by including quantitative questions to the CTN0096-1a National Tribal Addiction Survey (n=300) and examine the implementation and outcomes of COVID-19 policy and regulation changes at the Tribal, State, and Federal levels through qualitative interviews conducted among providers and consumers (n=50).
早在2020年2月,美国印第安人和阿拉斯加原住民(AI/AN)社区就开始报告 相对于美国其他地区,COVID-19的患病率有所增加。与非新住户工作者(21%)相比, 的AI/AN成年人患COVID-19相关严重疾病的风险最大。AI/AN成年人也更有可能 患有潜在的健康状况,进一步增加了对COVID-19感染的脆弱性,例如 糖尿病心血管疾病和癌症历史和政治因素加剧了这些风险 因素,包括天花和西班牙流感造成的人口崩溃, 印度卫生服务的现状、获得所需护理的障碍以及长期资金不足。到 生动地说明了COVID-19相关的差异,AI/AN人占新墨西哥州人口的11%,但 占该州COVID-19病例的55%以上,10纳瓦霍族报告确诊3,912例 140例死亡(截至2015年5月21日)。为了满足物质使用障碍患者的治疗需求, 特别是阿片类药物使用障碍(OUD),在COVID-19紧急情况下,联邦法规指导成瘾 服务的提供已经修改,包括在人工智能/人工智能社区内。变化包括扩展 远程医疗和虚拟行为健康服务,调整OUD的药物剂量策略, 改变成瘾服务的报销和保密政策和做法。虽然这些政策 转变是为了促进可用性和访问,对采用,实施和 这些变化在服务于AI/AN社区的计划中的有效性。迫切需要数据来提供信息 COVID-19紧急情况后的政策决定-也就是说,是否应进一步制定政策, 扩展或可选地回滚。为了确保未来有关戒毒服务的政策决定 包括AI/AN社区的经验和需求,对传播、采用和 在AI/AN服务成瘾治疗计划中实施联邦成瘾政策至关重要 重要性本研究的目标是迅速调查传播,采用,实施, 部落社区中维持物质使用和与COVID-19相关的政策变化。 具体目标是评估COVID-19的传播、采用和实施情况, 19政策和法规在部落,州,和联邦各级,包括定量问题, CTN 0096 -1a全国部落成瘾调查(n=300),并检查 通过定性访谈了解部落、州和联邦层面的COVID-19政策和法规变化 在供应商和消费者之间进行(n=50)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kimberly Page其他文献

Kimberly Page的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kimberly Page', 18)}}的其他基金

A Multi-Site Mixed Methods Study of Methamphetamine Use in the Mountain West
西部山区甲基苯丙胺使用的多地点混合方法研究
  • 批准号:
    10391845
  • 财政年份:
    2021
  • 资助金额:
    $ 14.86万
  • 项目类别:
A Multi-Site Mixed Methods Study of Methamphetamine Use in the Mountain West
西部山区甲基苯丙胺使用的多地点混合方法研究
  • 批准号:
    10491652
  • 财政年份:
    2021
  • 资助金额:
    $ 14.86万
  • 项目类别:
Exploring Health Beliefs for Community Engagement and Diversity in Clinical Trials
探索临床试验中社区参与和多样性的健康信念
  • 批准号:
    10399907
  • 财政年份:
    2021
  • 资助金额:
    $ 14.86万
  • 项目类别:
A Multi-Site Mixed Methods Study of Methamphetamine Use in the Mountain West
西部山区甲基苯丙胺使用的多地点混合方法研究
  • 批准号:
    10662433
  • 财政年份:
    2021
  • 资助金额:
    $ 14.86万
  • 项目类别:
Project-004
项目-004
  • 批准号:
    10874181
  • 财政年份:
    2019
  • 资助金额:
    $ 14.86万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10581505
  • 财政年份:
    2019
  • 资助金额:
    $ 14.86万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10379715
  • 财政年份:
    2019
  • 资助金额:
    $ 14.86万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10583148
  • 财政年份:
    2019
  • 资助金额:
    $ 14.86万
  • 项目类别:
Project-003
项目-003
  • 批准号:
    10874180
  • 财政年份:
    2019
  • 资助金额:
    $ 14.86万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10336027
  • 财政年份:
    2019
  • 资助金额:
    $ 14.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了